JPWO2020223541A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020223541A5 JPWO2020223541A5 JP2021564454A JP2021564454A JPWO2020223541A5 JP WO2020223541 A5 JPWO2020223541 A5 JP WO2020223541A5 JP 2021564454 A JP2021564454 A JP 2021564454A JP 2021564454 A JP2021564454 A JP 2021564454A JP WO2020223541 A5 JPWO2020223541 A5 JP WO2020223541A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- combination
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962841481P | 2019-05-01 | 2019-05-01 | |
| US62/841,481 | 2019-05-01 | ||
| US201962848248P | 2019-05-15 | 2019-05-15 | |
| US62/848,248 | 2019-05-15 | ||
| US201962898900P | 2019-09-11 | 2019-09-11 | |
| US62/898,900 | 2019-09-11 | ||
| PCT/US2020/030824 WO2020223541A1 (en) | 2019-05-01 | 2020-04-30 | Methods for treating or preventing asthma by administering an il-33 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022530533A JP2022530533A (ja) | 2022-06-29 |
| JPWO2020223541A5 true JPWO2020223541A5 (es) | 2023-05-12 |
Family
ID=70802932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564454A Pending JP2022530533A (ja) | 2019-05-01 | 2020-04-30 | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210000949A1 (es) |
| EP (1) | EP3962515A1 (es) |
| JP (1) | JP2022530533A (es) |
| KR (1) | KR20220004708A (es) |
| CN (1) | CN113766931A (es) |
| AU (1) | AU2020266593A1 (es) |
| BR (1) | BR112021021195A2 (es) |
| CA (1) | CA3138306A1 (es) |
| CO (1) | CO2021015793A2 (es) |
| IL (1) | IL287275A (es) |
| MA (1) | MA55807A (es) |
| MX (1) | MX2021013427A (es) |
| SG (1) | SG11202111255YA (es) |
| TW (1) | TW202106334A (es) |
| WO (1) | WO2020223541A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3470432T (pt) | 2012-08-21 | 2021-12-14 | Regeneron Pharma | Métodos para tratamento ou prevenção da asma por meio de administração de um antagonista de il-4r |
| MA46098A (fr) | 2016-09-01 | 2019-07-10 | Regeneron Pharma | Méthodes de prévention ou de traitement de l'allergie par administration d'un antagoniste d'il-4 r |
| CA3132587A1 (en) | 2019-03-21 | 2020-09-24 | Regeneron Pharmaceuticals, Inc. | Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy |
| AU2022335719A1 (en) | 2021-08-27 | 2024-04-11 | Medimmune Limited | Treatment of chronic obstructive pulmonary disease with an anti-interleukin-33 antibody |
| US20230272096A1 (en) * | 2021-11-11 | 2023-08-31 | Regeneron Pharmaceuticals, Inc. | Treatment Of Lung Disease Based Upon Stratification Of Polygenic Risk Score For Interleukin 33 (IL-33) |
| WO2024042212A1 (en) | 2022-08-26 | 2024-02-29 | Medimmune Limited | Treatment of asthma with an anti-interleukin-33 antibody |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US8178098B2 (en) | 2001-04-03 | 2012-05-15 | National Jewish Health | Method to inhibit airway hyperresponsiveness using aerosolized T cell receptor antibodies |
| MY159787A (en) | 2006-06-02 | 2017-01-31 | Regeneron Pharma | High affinity antibodies to human il-6 receptor |
| EA034617B1 (ru) | 2010-10-06 | 2020-02-27 | Ридженерон Фармасьютикалз, Инк. | Дозированная форма жидкой фармацевтической композиции, содержащей антитела к рецептору интерлейкина-4 (il-4r) |
| PT3470432T (pt) * | 2012-08-21 | 2021-12-14 | Regeneron Pharma | Métodos para tratamento ou prevenção da asma por meio de administração de um antagonista de il-4r |
| JO3532B1 (ar) * | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
| KR102368450B1 (ko) * | 2014-02-21 | 2022-02-28 | 사노피 바이오테크놀로지 | Ｉｌ-4ｒ 길항제의 투여에 의한 천식의 치료 또는 예방 방법 |
| TW202332696A (zh) * | 2016-12-01 | 2023-08-16 | 美商再生元醫藥公司 | 治療發炎症狀的方法 |
| EP3624820A1 (en) * | 2017-04-21 | 2020-03-25 | H. Hoffnabb-La Roche Ag | Use of klk5 antagonists for treatment of a disease |
-
2020
- 2020-04-30 WO PCT/US2020/030824 patent/WO2020223541A1/en active Application Filing
- 2020-04-30 EP EP20727763.3A patent/EP3962515A1/en active Pending
- 2020-04-30 CA CA3138306A patent/CA3138306A1/en active Pending
- 2020-04-30 MA MA055807A patent/MA55807A/fr unknown
- 2020-04-30 MX MX2021013427A patent/MX2021013427A/es unknown
- 2020-04-30 BR BR112021021195A patent/BR112021021195A2/pt unknown
- 2020-04-30 KR KR1020217038970A patent/KR20220004708A/ko unknown
- 2020-04-30 TW TW109114586A patent/TW202106334A/zh unknown
- 2020-04-30 US US16/863,800 patent/US20210000949A1/en active Pending
- 2020-04-30 SG SG11202111255YA patent/SG11202111255YA/en unknown
- 2020-04-30 JP JP2021564454A patent/JP2022530533A/ja active Pending
- 2020-04-30 CN CN202080032942.1A patent/CN113766931A/zh active Pending
- 2020-04-30 AU AU2020266593A patent/AU2020266593A1/en active Pending
-
2021
- 2021-10-14 IL IL287275A patent/IL287275A/en unknown
- 2021-11-24 CO CONC2021/0015793A patent/CO2021015793A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023052457A5 (es) | ||
| US20210380705A1 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| JP6463351B2 (ja) | Ｉｌ−４ｒアンタゴニストの投与により鼻茸を処置する方法 | |
| JP2015527364A5 (es) | ||
| US20160185866A1 (en) | Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist | |
| TWI477273B (zh) | 低頻率格拉替雷（ｇｌａｔｉｒａｍｅｒ）醋酸鹽之治療 | |
| JP2017507139A5 (es) | ||
| RU2015109716A (ru) | Способы лечения или предотвращения астмы посредством введения антагониста il-4r | |
| JP6746495B2 (ja) | ベンラリツマブを使用して喘息の増悪率を低減する方法 | |
| RU2012117563A (ru) | Режим дозирования модулятора рецептора s1p | |
| AU2020201277A1 (en) | Methods for increasing forced expiratory volume in asthmatics using benralizumab | |
| KR102337601B1 (ko) | 벤랄리주맙을 이용하여 천식 증상을 개선시키는 방법 | |
| TW201002345A (en) | Use of protease-activated receptor 2 antagonists | |
| EA034864B1 (ru) | Способ лечения эозинофильной астмы со степенью тяжести от умеренной до тяжёлой | |
| JPWO2020223541A5 (es) | ||
| US8877740B2 (en) | Compound composition for inhalation used for treating asthma | |
| JPWO2004028518A1 (ja) | 粘膜組織収縮性治療剤、粘膜組織に関わる疾患の治療方法、注射器、及び治療具セット | |
| RU2021134810A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-33 | |
| WO2014093818A2 (en) | Use of a novel subcutaneous needle-free technique to deliver testosterone in hypogonadal men | |
| JP2020105193A5 (es) | ||
| Melethil et al. | Physicians perspective and preference in the choice of metered dose inhaler with spacer vs nebulizer | |
| JPWO2021113707A5 (es) | ||
| RU2556792C1 (ru) | Способ анестезии при выполнении операции циклофотокоагуляция у пациентов с синдромом "хронической" боли | |
| JPWO2019186369A5 (es) | ||
| Chen et al. | Capsular Thyroid Injection Therapy Under Ultrasound Guidance for the Treatment of Subacute Thyroiditis |